Nanoparticle-enhanced PD-1/PD-L1 targeted combination therapy for triple negative breast cancer

Breast cancer with triple-negative subtype (TNBC) presents significant challenges with limited treatment options and a poorer prognosis than others. While PD-1/PD-L1 checkpoint inhibitors have shown promise, their efficacy in TNBC remains constrained. In recent years, nanoparticle (NP) technologies...

Full description

Bibliographic Details

Published in:	Frontiers in Oncology
Main Authors:	Caroline Linde, Yu-Ting Chien, Zhiqian Chen, Qingxin Mu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-05-01
Subjects:	nanoparticles triple negative breast cancer PD-1/PD-L1 pathway combination therapy tumor microenvironment
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2024.1393492/full